NEW YORK (GenomeWeb) – Boulder, Colorado-based MBio Diagnostics has received a $217,702 grant from the National Science Foundation to develop toxin testing technology.

The grant funds development of a portable platform to detect algal bloom toxins using the firm's multiplexed fluorescence immunoassay Array System and LightDeck fluorescence assay illumination technology.

"MBio has demonstrated a unique, portable testing platform that delivers a panel of freshwater and marine toxin test results in a matter of minutes in an easy-to-use format," the firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.

Nov
14
Sponsored by
PerkinElmer

In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.